1. Home
  2. Advocacy
  3. Latest News and Practice Data
  4. ICYMI - Updates from the FDA on the EUA Process

The CAP hosted a webinar to discuss updates to the Food and Drug Administration (FDA) Emergency Use Authorization (EUA) process on October 25. The FDA’s Timothy Stenzel, MD, PhD, who is the Director of the FDA Office of In Vitro Diagnostics and Radiological Health, and Toby Lowe who is the Associate Director for Regulatory Programs in Office of In Vitro Diagnostics and Radiological Health, provided pathologists with an overview of current EUA processes and answered questions.

Check out the recording and download the slides.

Most Recent Content

  1. March 17, 2026
  2. CAP responds to federal RFI on diagnostic imaging standards
  3. Virginia passes legislation allowing delayed release of certain pathology test results
  4. Amplify your advocacy at HOD/PLS26
  5. CAP engages with HRSA on pathologist workforce projections
  6. View All